Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma.

Takahashi Y, Bell D, Agarwal G, Roberts D, Xie TX, El-Naggar A, Myers JN, Hanna EY.

Head Neck. 2014 Aug;36(8):1094-102. doi: 10.1002/hed.23423. Epub 2013 Oct 26.

PMID:
23836481
2.

Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.

Fischer C, Zlobec I, Stöckli E, Probst S, Storck C, Tornillo L, Lugli A, Wolfensberger M, Terracciano L.

Hum Pathol. 2008 Oct;39(10):1527-34. doi: 10.1016/j.humpath.2008.03.001. Epub 2008 Jul 11.

PMID:
18620726
3.

c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.

Baschnagel AM, Williams L, Hanna A, Chen PY, Krauss DJ, Pruetz BL, Akervall J, Wilson GD.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):701-7. doi: 10.1016/j.ijrobp.2013.11.013.

PMID:
24521684
4.

Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.

Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT.

Cancer. 2007 Feb 15;109(4):658-67. Erratum in: Cancer. 2009 May 1;115(9):2024. Reseetkova, Erika [corrected to Resetkova, Erika].

5.
6.

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ.

J Natl Cancer Inst. 1998 Jun 3;90(11):824-32.

PMID:
9625170
7.

Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.

Gaffney DK, Haslam D, Tsodikov A, Hammond E, Seaman J, Holden J, Lee RJ, Zempolich K, Dodson M.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):922-8.

PMID:
12829126
8.

Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.

Gröbe A, Eichhorn W, Fraederich M, Kluwe L, Vashist Y, Wikner J, Smeets R, Simon R, Sauter G, Heiland M, Blessmann M.

J Oral Pathol Med. 2014 Mar;43(3):205-10. doi: 10.1111/jop.12111. Epub 2013 Sep 11.

PMID:
24020871
9.
10.

High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.

Gately K, Forde L, Cuffe S, Cummins R, Kay EW, Feuerhake F, O'Byrne KJ.

Clin Lung Cancer. 2014 Jan;15(1):58-66. doi: 10.1016/j.cllc.2013.08.005. Epub 2013 Nov 7.

PMID:
24210543
11.

Epstein-Barr virus infection is strictly associated with the metastatic spread of sinonasal squamous-cell carcinomas.

Doescher J, Piontek G, Wirth M, Bettstetter M, Schlegel J, Haller B, Brockhoff G, Reiter R, Pickhard A.

Oral Oncol. 2015 Oct;51(10):929-34. doi: 10.1016/j.oraloncology.2015.07.008. Epub 2015 Aug 10.

PMID:
26272275
12.

High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma.

Udager AM, Rolland DC, McHugh JB, Betz BL, Murga-Zamalloa C, Carey TE, Marentette LJ, Hermsen MA, DuRoss KE, Lim MS, Elenitoba-Johnson KS, Brown NA.

Cancer Res. 2015 Jul 1;75(13):2600-6. doi: 10.1158/0008-5472.CAN-15-0340. Epub 2015 Apr 30.

13.

Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma.

López F, Llorente JL, Oviedo CM, Vivanco B, Marcos CÁ, García-Inclán C, Scola B, Hermsen MA.

Cancer. 2012 Apr 1;118(7):1818-26. doi: 10.1002/cncr.26451. Epub 2011 Aug 25.

14.

High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis.

Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, Barbieri V, Jank S, Doppler W, Rasse M, Norer B.

Oral Oncol. 2007 Feb;43(2):193-8. Epub 2006 Jul 18.

PMID:
16854613
15.

SOX2 expression in hypopharyngeal, laryngeal, and sinonasal squamous cell carcinoma.

González-Márquez R, Llorente JL, Rodrigo JP, García-Pedrero JM, Álvarez-Marcos C, Suárez C, Hermsen MA.

Hum Pathol. 2014 Apr;45(4):851-7. doi: 10.1016/j.humpath.2013.12.004. Epub 2013 Dec 21.

PMID:
24656096
16.

Co-expression of EGFR and CK5/6 in primary squamous cell carcinoma of the breast.

Wang J, Zhang X, He J, Yang M, Tang J, Li X, Tang H, Xie X.

Med Oncol. 2014 Sep;31(9):172. doi: 10.1007/s12032-014-0172-8. Epub 2014 Aug 15.

PMID:
25119504
17.

Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma.

Fujii M, Yamashita T, Ishiguro R, Tashiro M, Kameyama K.

Auris Nasus Larynx. 2002 Apr;29(2):175-81.

PMID:
11893453
18.

Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas.

Imamhasan A, Mitomi H, Saito T, Hayashi T, Takahashi M, Kajiyama Y, Yao T.

Hum Pathol. 2012 Nov;43(11):2012-23. doi: 10.1016/j.humpath.2012.02.010. Epub 2012 May 18.

PMID:
22607702
19.

Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.

Yamamoto Y, Yamai H, Seike J, Yoshida T, Takechi H, Furukita Y, Kajiura K, Minato T, Bando Y, Tangoku A.

Ann Surg Oncol. 2012 Mar;19(3):757-65. doi: 10.1245/s10434-011-2071-y. Epub 2011 Sep 27.

PMID:
21947696
20.

Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma.

Huang SF, Cheng SD, Chien HT, Liao CT, Chen IH, Wang HM, Chuang WY, Wang CY, Hsieh LL.

Oral Oncol. 2012 Jan;48(1):67-72. doi: 10.1016/j.oraloncology.2011.06.511. Epub 2011 Aug 9.

PMID:
21831696

Supplemental Content

Support Center